annual CFF:
$10.91M-$2.75M(-20.16%)Summary
- As of today (June 22, 2025), TXG annual cash flow from financing activities is $10.91 million, with the most recent change of -$2.75 million (-20.16%) on December 31, 2024.
- During the last 3 years, TXG annual CFF has fallen by -$24.38 million (-69.08%).
- TXG annual CFF is now -97.67% below its all-time high of $468.91 million, reached on December 31, 2020.
Performance
TXG Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$422.00K-$4.09M(-90.66%)Summary
- As of today (June 22, 2025), TXG quarterly cash flow from financing activities is $422.00 thousand, with the most recent change of -$4.09 million (-90.66%) on March 31, 2025.
- Over the past year, TXG quarterly CFF has dropped by -$1.22 million (-74.24%).
- TXG quarterly CFF is now -99.91% below its all-time high of $486.97 million, reached on September 30, 2020.
Performance
TXG quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$9.70M-$1.22M(-11.14%)Summary
- As of today (June 22, 2025), TXG TTM cash flow from financing activities is $9.70 million, with the most recent change of -$1.22 million (-11.14%) on March 31, 2025.
- Over the past year, TXG TTM CFF has dropped by -$9.02 million (-48.20%).
- TXG TTM CFF is now -98.11% below its all-time high of $514.38 million, reached on June 30, 2021.
Performance
TXG TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TXG Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.2% | -74.2% | -48.2% |
| 3 y3 years | -69.1% | -82.5% | -71.6% |
| 5 y5 years | -97.4% | +101.3% | -97.5% |
TXG Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -69.1% | at low | -94.0% | +112.4% | -71.6% | at low |
| 5 y | 5-year | -97.7% | at low | -99.9% | +101.3% | -98.1% | at low |
| alltime | all time | -97.7% | at low | -99.9% | +101.3% | -98.1% | >+9999.0% |
TXG Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $422.00K(-90.7%) | $9.70M(-11.1%) |
| Dec 2024 | $10.91M(-20.2%) | $4.52M(+2795.5%) | $10.91M(-9.1%) |
| Sep 2024 | - | $156.00K(-96.6%) | $12.01M(-26.0%) |
| Jun 2024 | - | $4.60M(+181.0%) | $16.23M(-13.3%) |
| Mar 2024 | - | $1.64M(-70.8%) | $18.72M(+37.0%) |
| Dec 2023 | $13.67M(-13.6%) | $5.61M(+28.3%) | $13.67M(+4.7%) |
| Sep 2023 | - | $4.37M(-38.4%) | $13.06M(+21.8%) |
| Jun 2023 | - | $7.10M(-307.9%) | $10.72M(+7.4%) |
| Mar 2023 | - | -$3.41M(-168.3%) | $9.99M(-36.9%) |
| Dec 2022 | $15.82M(-55.2%) | $5.00M(+145.3%) | $15.82M(-19.8%) |
| Sep 2022 | - | $2.04M(-67.9%) | $19.72M(-19.1%) |
| Jun 2022 | - | $6.36M(+163.1%) | $24.36M(-28.8%) |
| Mar 2022 | - | $2.42M(-72.9%) | $34.20M(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $35.30M(-92.5%) | $8.90M(+33.2%) | $35.30M(+3.5%) |
| Sep 2021 | - | $6.68M(-58.7%) | $34.10M(-93.4%) |
| Jun 2021 | - | $16.19M(+360.3%) | $514.38M(+1.6%) |
| Mar 2021 | - | $3.52M(-54.3%) | $506.24M(+8.0%) |
| Dec 2020 | $468.91M(+13.1%) | $7.71M(-98.4%) | $468.91M(+1.9%) |
| Sep 2020 | - | $486.97M(+5948.5%) | $460.09M(+18.3%) |
| Jun 2020 | - | $8.05M(-123.8%) | $388.76M(+2.3%) |
| Mar 2020 | - | -$33.82M(+2955.0%) | $379.85M(-8.4%) |
| Dec 2019 | $414.59M(+293.5%) | -$1.11M(-100.3%) | $414.59M(-0.3%) |
| Sep 2019 | - | $415.64M(<-9900.0%) | $415.70M(>+9900.0%) |
| Jun 2019 | - | -$864.00K(-193.6%) | $59.00K(-93.6%) |
| Mar 2019 | - | $923.00K | $923.00K |
| Dec 2018 | $105.37M(+411.9%) | - | - |
| Dec 2017 | $20.58M | - | - |
FAQ
- What is 10x Genomics annual cash flow from financing activities?
- What is the all time high annual CFF for 10x Genomics?
- What is 10x Genomics annual CFF year-on-year change?
- What is 10x Genomics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for 10x Genomics?
- What is 10x Genomics quarterly CFF year-on-year change?
- What is 10x Genomics TTM cash flow from financing activities?
- What is the all time high TTM CFF for 10x Genomics?
- What is 10x Genomics TTM CFF year-on-year change?
What is 10x Genomics annual cash flow from financing activities?
The current annual CFF of TXG is $10.91M
What is the all time high annual CFF for 10x Genomics?
10x Genomics all-time high annual cash flow from financing activities is $468.91M
What is 10x Genomics annual CFF year-on-year change?
Over the past year, TXG annual cash flow from financing activities has changed by -$2.75M (-20.16%)
What is 10x Genomics quarterly cash flow from financing activities?
The current quarterly CFF of TXG is $422.00K
What is the all time high quarterly CFF for 10x Genomics?
10x Genomics all-time high quarterly cash flow from financing activities is $486.97M
What is 10x Genomics quarterly CFF year-on-year change?
Over the past year, TXG quarterly cash flow from financing activities has changed by -$1.22M (-74.24%)
What is 10x Genomics TTM cash flow from financing activities?
The current TTM CFF of TXG is $9.70M
What is the all time high TTM CFF for 10x Genomics?
10x Genomics all-time high TTM cash flow from financing activities is $514.38M
What is 10x Genomics TTM CFF year-on-year change?
Over the past year, TXG TTM cash flow from financing activities has changed by -$9.02M (-48.20%)